FDA's Crawford Readies Himself For "Intense Week" Of Congressional Hearings
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Acting Commissioner Lester Crawford will appear in front of four congressional committees this week in what amounts to "the most intense week of congressional hearings that we have had in FDA's history," he said
You may also be interested in...
New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads
The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.
FDA's Cure For The Flu: Orphan Drug-Like Incentives, Tissue-Based Production
The agency plans to request congressional action on influenza vaccine incentives during three hearings on the flu vaccine shortage. FDA, in cooperation with U.K. regulatory officials, will determine in January whether Chiron will be able to manufacture Fluvirin at the company’s Liverpool facility for the 2005-06 flu season.
New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads
The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.